Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients

Jr Raszka, R. A. Moriarty, M. G. Ottolini, N. J. Waecker, D. P. Ascher, T. J. Cieslak, G. W. Fischer, M. L. Robb

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To evaluate whether pediatric patients infected with human immunodeficiency virus (HIV) can mount appropriate delayed-type hypersensitivity (DTH) skin responses to recall antigens and whether these responses can be correlated with clinical or immunologic parameters. Design: Prospective evaluation of DTH responses in HIV-infected children. Uninfected children born to HIV-infected mothers served as control subjects. Antigens used for yearly DTH testing included Candida albicans (1:100, 1:10); mumps virus; Trichophyton; purified protein derivative of tuberculin; and tetanus toxoid (1:100, 1:10). At the time of each DTH test, patients were staged according to two Centers for Disease Control and Prevention pediatric HIV classification systems, and T-cell subsets were obtained. Results: Twenty- seven HIV-infected patients with a median age at entry of 74,1 (range, 12 to 156) months were followed. Forty-four DTH skin tests in 21 symptom-free HIV- infected patients (P1) and 18 tests in 10 HIV-infected patients with symptoms (P2), as well as 43 DTH skin tests in 18 patients who had either mild or moderate clinical symptoms or immunosuppression and 19 tests in 13 patients with severe symptoms or immunosuppression, were evaluated. Sixteen DTH skin tests were performed in 14 uninfected patients. HIV-infected patients tended to have fewer DTH responses to antigens and of smaller size than did uninfected patients. When controlled for age, few differences in DTH responsiveness were seen between HIV-infected and uninfected patients. Anergy was associated with symptomatic disease, evidence of advanced clinical or immunologic disease, and low CD4+ percentages (p <0.05). Conclusions: HIV- infected children are able to mount antigen-specific cell-mediated immune responses that are qualitatively similar to those of age-matched control subjects. Loss of DTH responsiveness correlates with both clinical and immunologic evidence of HIV disease progression.

Original languageEnglish (US)
Pages (from-to)245-250
Number of pages6
JournalJournal of Pediatrics
Volume129
Issue number2
DOIs
StatePublished - Jan 1 1996

Fingerprint

Delayed Hypersensitivity
HIV
Pediatrics
Skin
Skin Tests
Antigens
Immunosuppression
Mumps virus
Trichophyton
Tetanus Toxoid
Tuberculin
Immune System Diseases
T-Lymphocyte Subsets
Virus Diseases
Centers for Disease Control and Prevention (U.S.)
Candida albicans
Disease Progression
Mothers

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients. / Raszka, Jr; Moriarty, R. A.; Ottolini, M. G.; Waecker, N. J.; Ascher, D. P.; Cieslak, T. J.; Fischer, G. W.; Robb, M. L.

In: Journal of Pediatrics, Vol. 129, No. 2, 01.01.1996, p. 245-250.

Research output: Contribution to journalArticle

Raszka, J, Moriarty, RA, Ottolini, MG, Waecker, NJ, Ascher, DP, Cieslak, TJ, Fischer, GW & Robb, ML 1996, 'Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients', Journal of Pediatrics, vol. 129, no. 2, pp. 245-250. https://doi.org/10.1016/S0022-3476(96)70249-4
Raszka, Jr ; Moriarty, R. A. ; Ottolini, M. G. ; Waecker, N. J. ; Ascher, D. P. ; Cieslak, T. J. ; Fischer, G. W. ; Robb, M. L. / Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients. In: Journal of Pediatrics. 1996 ; Vol. 129, No. 2. pp. 245-250.
@article{c272213b034f44838f8656b7a63ce953,
title = "Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients",
abstract = "Objective: To evaluate whether pediatric patients infected with human immunodeficiency virus (HIV) can mount appropriate delayed-type hypersensitivity (DTH) skin responses to recall antigens and whether these responses can be correlated with clinical or immunologic parameters. Design: Prospective evaluation of DTH responses in HIV-infected children. Uninfected children born to HIV-infected mothers served as control subjects. Antigens used for yearly DTH testing included Candida albicans (1:100, 1:10); mumps virus; Trichophyton; purified protein derivative of tuberculin; and tetanus toxoid (1:100, 1:10). At the time of each DTH test, patients were staged according to two Centers for Disease Control and Prevention pediatric HIV classification systems, and T-cell subsets were obtained. Results: Twenty- seven HIV-infected patients with a median age at entry of 74,1 (range, 12 to 156) months were followed. Forty-four DTH skin tests in 21 symptom-free HIV- infected patients (P1) and 18 tests in 10 HIV-infected patients with symptoms (P2), as well as 43 DTH skin tests in 18 patients who had either mild or moderate clinical symptoms or immunosuppression and 19 tests in 13 patients with severe symptoms or immunosuppression, were evaluated. Sixteen DTH skin tests were performed in 14 uninfected patients. HIV-infected patients tended to have fewer DTH responses to antigens and of smaller size than did uninfected patients. When controlled for age, few differences in DTH responsiveness were seen between HIV-infected and uninfected patients. Anergy was associated with symptomatic disease, evidence of advanced clinical or immunologic disease, and low CD4+ percentages (p <0.05). Conclusions: HIV- infected children are able to mount antigen-specific cell-mediated immune responses that are qualitatively similar to those of age-matched control subjects. Loss of DTH responsiveness correlates with both clinical and immunologic evidence of HIV disease progression.",
author = "Jr Raszka and Moriarty, {R. A.} and Ottolini, {M. G.} and Waecker, {N. J.} and Ascher, {D. P.} and Cieslak, {T. J.} and Fischer, {G. W.} and Robb, {M. L.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/S0022-3476(96)70249-4",
language = "English (US)",
volume = "129",
pages = "245--250",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients

AU - Raszka, Jr

AU - Moriarty, R. A.

AU - Ottolini, M. G.

AU - Waecker, N. J.

AU - Ascher, D. P.

AU - Cieslak, T. J.

AU - Fischer, G. W.

AU - Robb, M. L.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Objective: To evaluate whether pediatric patients infected with human immunodeficiency virus (HIV) can mount appropriate delayed-type hypersensitivity (DTH) skin responses to recall antigens and whether these responses can be correlated with clinical or immunologic parameters. Design: Prospective evaluation of DTH responses in HIV-infected children. Uninfected children born to HIV-infected mothers served as control subjects. Antigens used for yearly DTH testing included Candida albicans (1:100, 1:10); mumps virus; Trichophyton; purified protein derivative of tuberculin; and tetanus toxoid (1:100, 1:10). At the time of each DTH test, patients were staged according to two Centers for Disease Control and Prevention pediatric HIV classification systems, and T-cell subsets were obtained. Results: Twenty- seven HIV-infected patients with a median age at entry of 74,1 (range, 12 to 156) months were followed. Forty-four DTH skin tests in 21 symptom-free HIV- infected patients (P1) and 18 tests in 10 HIV-infected patients with symptoms (P2), as well as 43 DTH skin tests in 18 patients who had either mild or moderate clinical symptoms or immunosuppression and 19 tests in 13 patients with severe symptoms or immunosuppression, were evaluated. Sixteen DTH skin tests were performed in 14 uninfected patients. HIV-infected patients tended to have fewer DTH responses to antigens and of smaller size than did uninfected patients. When controlled for age, few differences in DTH responsiveness were seen between HIV-infected and uninfected patients. Anergy was associated with symptomatic disease, evidence of advanced clinical or immunologic disease, and low CD4+ percentages (p <0.05). Conclusions: HIV- infected children are able to mount antigen-specific cell-mediated immune responses that are qualitatively similar to those of age-matched control subjects. Loss of DTH responsiveness correlates with both clinical and immunologic evidence of HIV disease progression.

AB - Objective: To evaluate whether pediatric patients infected with human immunodeficiency virus (HIV) can mount appropriate delayed-type hypersensitivity (DTH) skin responses to recall antigens and whether these responses can be correlated with clinical or immunologic parameters. Design: Prospective evaluation of DTH responses in HIV-infected children. Uninfected children born to HIV-infected mothers served as control subjects. Antigens used for yearly DTH testing included Candida albicans (1:100, 1:10); mumps virus; Trichophyton; purified protein derivative of tuberculin; and tetanus toxoid (1:100, 1:10). At the time of each DTH test, patients were staged according to two Centers for Disease Control and Prevention pediatric HIV classification systems, and T-cell subsets were obtained. Results: Twenty- seven HIV-infected patients with a median age at entry of 74,1 (range, 12 to 156) months were followed. Forty-four DTH skin tests in 21 symptom-free HIV- infected patients (P1) and 18 tests in 10 HIV-infected patients with symptoms (P2), as well as 43 DTH skin tests in 18 patients who had either mild or moderate clinical symptoms or immunosuppression and 19 tests in 13 patients with severe symptoms or immunosuppression, were evaluated. Sixteen DTH skin tests were performed in 14 uninfected patients. HIV-infected patients tended to have fewer DTH responses to antigens and of smaller size than did uninfected patients. When controlled for age, few differences in DTH responsiveness were seen between HIV-infected and uninfected patients. Anergy was associated with symptomatic disease, evidence of advanced clinical or immunologic disease, and low CD4+ percentages (p <0.05). Conclusions: HIV- infected children are able to mount antigen-specific cell-mediated immune responses that are qualitatively similar to those of age-matched control subjects. Loss of DTH responsiveness correlates with both clinical and immunologic evidence of HIV disease progression.

UR - http://www.scopus.com/inward/record.url?scp=0030391748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030391748&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(96)70249-4

DO - 10.1016/S0022-3476(96)70249-4

M3 - Article

C2 - 8765622

AN - SCOPUS:0030391748

VL - 129

SP - 245

EP - 250

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -